ARTICLE | Top Story
FDA approves Campral
July 30, 2004 7:00 AM UTC
FDA granted marketing approval to Forest (FRX) and Merck KGaA (FSE:MRK) for Campral to treat alcohol dependence in patients who are abstinent from alcohol at treatment initiation. Under a 2001 deal, F...